Abu Dhabi health ministry recalls cholesterol drug

The drug was under review for conformity standards.

Abu Dhabi's Ministry of Health and Community Prevention has suspended the registration of Lipodar, a drug used to lower blood cholesterol levels at concentrations sold in 10, 20, 40 and 80mg.
This decision was made after the central drug registration committee suspended the product after ascertaining its did not confirm with specifications noted for the original product, reported Al Bayan.
They requested the manufacturer "Dar Al Dawa" to conduct a new study for bioequivalence for the product this year.
The product's registration is slated to be cancelled if the study is not submitted.
The Department of Health Abu Dhabi, has requested the withdrawal of the product from the emirate's markets.
Agents are requested to recall all Lipodar products from pharmacies.
The department called on healthcare practitioners to report side effects resulting from the product.

• Abu Dhabi